US Patent 7867511 Abuse potential reduction in abusable substance dosage form
Patent 7867511 was granted and assigned to Travanti Pharma on January, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+309 characters)
Article
Patent abstract
The potential for substance abuse involving residual amounts of abusable substances remaining in used skin-worn patches is reduced by the provision of a system and method for combining the abusable substance with a separate anti-abuse substance agent as part of a removal or disposal procedure.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Carter R. Anderson0
Russell L. Morris0
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07867511 Abuse potential reduction in abusable substance dosage form US Patent 7867511 Abuse potential reduction in abusable substance dosage form
Infobox
Patent Number
07867511
Patent Number
7867511
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07867511 Abuse potential reduction in abusable substance dosage form
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07867511
Date of patent
January 11, 2011
Patent application number
10763628
Date Filed
January 23, 2004
Patent primary examiner
Find more entities like US Patent 7867511 Abuse potential reduction in abusable substance dosage form
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
